Clinical Trial Update: A Translational Study for Phenotyping and Endotyping Chinese Patients With NCFBE

View source ↗

Summary

A translational study in Chinese patients with Non-cystic fibrosis bronchiectasis aims to phenotype and endotype the disease and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-cystic Fibrosis Bronchiectasis

Snippet

Sponsor: AstraZeneca | Conditions: Non-cystic Fibrosis Bronchiectasis | Status: RECRUITING